More specifically, four gene mutations (LRP1B, MLH1, EPHA5, and NTRK2) were only present in the NSCLC coexisting COPD group, which was not true for the NSCLC alone group. The gene discussed is EPHA5; the disease is chronic obstructive pulmonary disease.